Molecular aspects of tumor cell migration and invasion

Annali dell'Istituto Superiore di Sanita

Volumn 46, Issue 1, 2010, Pages 66-80

  Bozzuto, Giuseppina ^a   Ruggieri, Paola ^a   Molinari, Agnese ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Molecular markers; Neoplasm invasion; Neoplasms

Indexed keywords

CELL ADHESION MOLECULE; METALLOPROTEINASE;

ARTICLE; BIOCHEMISTRY; CANCER INVASION; DRUG RESISTANCE; EXTRACELLULAR MATRIX; HUMAN; PHYSIOLOGY; TUMOR EMBOLISM;

BIOCHEMICAL PROCESSES; CELL ADHESION MOLECULES; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX; HUMANS; METALLOPROTEASES; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING;

EID: 77955077505     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.4415/ANN-10-01-09     Document Type: Article

References (138)

1. von der Mark K, Schöber S, Goodman SL. Integrins in cell migration. Methods Mol Biol 1999;129:219-30.
2. Cho SY, Klemke RL. Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 2000;149:223-36. (Pubitemid 30196711)
3. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nature Rev Canc 2004;4:448-56. (Pubitemid 38745530)
4. Liotta LA, Kleinerman J, Catanzaro P, Rynbrandt D. Degradation of basement membrane by murine tumor cells. J Natl Cancer Inst 1977;58:1427-31. (Pubitemid 8096310)
5. Friedl P, Bröcker EB. The biology of cell locomotion with three-dimensional extracellular matrix. Cell Mol Life Sci 2000;57:41-64. (Pubitemid 30105329)
6. Abercrombie M, Dunn GA, Heath JP. The shape and movement of fibroblasts in culture. Soc Gen Physiol Ser 1977;32:57-70.
7. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359-69. (Pubitemid 26058561)
8. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003;112:453-65. (Pubitemid 36263079)
9. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, Kirschner MW. The interaction between NWASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 1999;97:221-31.
10. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999;68:459-86. (Pubitemid 29449200)
11. Adams JC. Cell-matrix contact structures. Cell Mol Life Sci 2001;58:371-92. (Pubitemid 32231973)
12. Cramer LP. Organization and polarity of actin filament networks in cells: implications for the mechanism of myosin-based cell motility. Biochem Socy Symp 1999;65:173-205. (Pubitemid 129541620)
13. Pontieri GM. Patologia Generale (2 Ed.). Padova: Piccin; 1996. p. 888-94.
14. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 2005;6:622-34. (Pubitemid 41081266)
15. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008;65:3756-88.
16. Strumane K, Berx G, Van Roy F. Cadherins in cancer. In: Behrens J, Nelson J. (Eds.). Cell Adhesion vol. 165, Heidelberg: Springer-Verlag; 2004. p. 69-103.
17. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85. (Pubitemid 21909684)
18. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-19. (Pubitemid 121001351)
19. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3. (Pubitemid 28162793)
20. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365-400. (Pubitemid 20135632)
21. Leitinger B, Hohenester E. Mammalian collagen receptors. Matrix Biol 2007;26:146-55. (Pubitemid 46401227)
22. Caswell P, Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol 2008;18:257-63.
23. Gilcrease MZ, Truong L, Brown RW. Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas. Hum Pathol 1996;27:1355-60. (Pubitemid 26415332)
24. Hynes RO. Integrin: bidirectional, allosteric signaling machines. Cell 2002;110:673-87. (Pubitemid 35283958)
25. Chammas R, Brentani R. Integrins and metastases: an overview. Tumour Biol 1991;12:309-20.
26. Burridge K, Fath K, Kelly T, Nuckolls G, Turner C. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol 1988;4:487-525. (Pubitemid 19139264)
27. Albeda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17.
28. Hogg N, Landis RC. Adhesion molecules in cell interactions. Curr Opin Immunol 1993;5:383-90. (Pubitemid 23197450)
29. Ruoslahti E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989;1:119-26. (Pubitemid 20191098)
30. Shimizu Y, Shaw S. Lymphocyte interactions with extracellular matrix. Faseb J 1991;5:2292-9. (Pubitemid 21892906)
31. Ferguson TA, Mizutani H, Kupper TS. Two integrin-binding peptides abrogate T-cell-mediated immune responses in vivo. Proc Natl Acad Sci USA 1991;88:8072-6. (Pubitemid 21915298)
32. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lynphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4. (Pubitemid 23004805)
33. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24. (Pubitemid 121001209)
34. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997;71:241-319. (Pubitemid 27197761)
35. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004;95:930-5. (Pubitemid 40089583)
36. Santini MT, Rainaldi G, Ferrante A, Indovina P, Donelli G, Indovina PL. A 50 Hz sinusoidal magnetic field does not damage MG-63 three-dimensional tumor spheroids but induces changes in their invasive properties. Bioelectromagnetics 2006;27:132-41.
37. Legg JW, Isacke CM. Identification and functional analysis in the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol 1998;8:705-8. (Pubitemid 28286278)
38. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S, Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998;140:885-95. (Pubitemid 28141226)
39. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW. Rhokinase (ROK) promotes CD44v (3, 8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 1999;43:269-87. (Pubitemid 29368201)
40. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3:586-99.
41. Gautreau A, Louvard D, Arpin M. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol 2002;14:104-9. (Pubitemid 34131663)
42. Zamir E, Katz M, Posen Y, Erez N, Yamada KM, Katz BZ, Lin S, Lin DC, Bershadsky A, Kam Z, Geiger B. Dynamics and segregation of cell-matrix adhesions in cultured fibroblasts. Nat Cell Biol 2000;2:191-6.
43. Zamir E, Geiger B. Components of cell-matrix adhesions. J Cell Sci 2001;114:3577-9. (Pubitemid 33041039)
44. Degani S, Balzac F, Brancaccio M, Guazzone S, Retta SF, Silengo L, Eva A, Tarone G. The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading. J Cell Biol 2002;156:377-88.
45. Schwartz MA, Shattil SJ. Signaling networks linking integrins and rho family GTPases. Trends Biochem Sci 2000;25:388-91. (Pubitemid 30497250)
46. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Betacatenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797-804.
47. Bhatt A, Kaverina I, Otey C, Huttenlocher A. Regulation of focal complex composition and disassembly by the calciumdependent protease calpain. J Cell Sci 2002;115:3415-25. (Pubitemid 34994031)
48. Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci 2005;118:3829-38. (Pubitemid 41410267)
49. Friedl P, Wolf K. Tumor-cell invasion and migration: diversity and escape mechanisms. Nat Rev Caner 2003;3:362-74. (Pubitemid 37328856)
50. Polte TR, Eichler GS, Wang N, Ingber DE. Extracellular matrix controls myosin light chain phosphorylation and cell contractility through modulation of cell shape and cytoskeletal prestress. Am J Physiol Cell Physiol 2004;286:C518-28.
51. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997;385:537-40. (Pubitemid 27074672)
52. Ballestrem C, Hinz B, Imhof BA. Wehrle-Haller B. Marching at the front and dragging behind: differential alphaVbeta3-integrin turnover regulates focal adhesion behavior. J Cell Biol 2001;155:1319-32. (Pubitemid 34286280)
53. Hall A. Ras-related GTPases and the cytoskeleton. Mol Biol Cell 1992;3:475-9. (Pubitemid 23079749)
54. Fukata Y, Kaibuchi K, Amano M, Kaibichi K. Rho-Rhokinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001;22:32-9. (Pubitemid 32126284)
55. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-56. (Pubitemid 36648590)
56. Vasiliev JM. Cytoskeletal mechanism responsible for invasive migration of neoplastic cells. Int J Dev Biol 2004;48:425-39. (Pubitemid 39360393)
57. Geiger B, Bershadsky A. Exploring the neighborhood: adhesioncoupled cell mechanosensors. Cell 2002;110:139-42. (Pubitemid 34876542)
58. Katoh K, Kano Y, Amano M, Onishi H, Kaibuchi K, Fujiwara K. Rho-kinase-mediated contraction of isolated stress fibers. J Cell Biol 2001;153:560-84.
59. Chew TL, Wolf WA, Gallagher PJ, Matsumura F, Chisholm RL. A fluorescent resonant energy transfer-based biosensor reveals transient and regional myosin light chain kinase activation in lamella and cleavage furrows J Cell Biol 2002;156:543-53.
60. Totsukawa G, Wu Y, Sasaki Y, Hartshorne DJ, Yamakita Y, Yamashiro S, Matsumura F. Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts. J Cell Biol 2004;164:427-39. (Pubitemid 38174770)
61. Somlyo AV, Phelps C, Dipierro C, Eto M, Read P, Barrett M, Gibson JJ, Burnitz MC, Myers C, Somlyo AP. Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. Faseb J 2003;17:223-34. (Pubitemid 36164392)
62. Geho DH, Bandle RW, Clair T, Liotta AL. Physiological mechanism of tumor-cell invasion and migration. Physiology 2005;20:194-200. (Pubitemid 40807057)
63. Stylli SS, Kaye AH, Lock P. Invadopodia: at the cutting edge of tumor invasion. J Clin Neurosci 2008;15:725-37.
64. Chen WT. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J Exp Zool 1989;251:167-85.
65. Kelly T, Yan Y, Osborne RL, Athota AB, Rozypal TL, Colclasure JC, Chu WS. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998;16:501-12. (Pubitemid 29009586)
66. Tarone G, Cirillo D, Giancotti FG, Comoglio PM, Marchisio PC. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp Cell Res 1985;159:141-57. (Pubitemid 16247561)
67. Chen WT, Lee CC, Goldstein L, Bernier S, Liu CH, Lin CY, Yeh Y, Monsky WL, Kelly T, Dai M. Zhou J-Y, Mueller SC. Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res Treat 1994;31:217-26. (Pubitemid 24323463)
68. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004;5:647-57. (Pubitemid 39025065)
69. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007;17:107-17. (Pubitemid 46341826)
70. Artym VV, Zhang Y, Seillier-Moiseiwitsch, F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006;66:3034-43.
71. Lorenz M, Yamaguchi H, Wang Y, Singer RH, Condeelis J. Imaging sites of N-wasp activity in lamellipodia and invadopodia of carcinoma cells. Curr Biol 2004;14:697:703.
72. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007;67:4227-35. (Pubitemid 46815069)
73. Mizutani K, Miki H, He H, Maruta H, Takenawa T. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res 2002;62:669-74. (Pubitemid 34126939)
74. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999;5:4440-9. (Pubitemid 29396652)
75. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 2005;168:441-52. (Pubitemid 40205066)
76. Onodera Y, Hashimoto S, Hashimoto A, Morishige M, Mazaki Y, Yamada A, Ogawa E, Adachi M, Sakurai T, Manabe T, Wada H, Matsuura N, Sabe H. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J 2005;24:963-73. (Pubitemid 40470145)
77. Seals DF, Azucena EF Jr, Pass I, Tesfay L, Gordon R, Woodrow M, Resau JH, Courtneidge SA. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 2005;7:155-65. (Pubitemid 40248341)
78. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the exstracellular matrix during invasion and metastasis. Annu Rev Cell Biol, 1993;9:541-73.
79. Nagase H, Woessner J F Jr. Matrix metalloproteinase. J Biol Chem 1999;274:21491-4.
80. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair. Int J Mol Med 2000;6:391-407.
81. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-30. (Pubitemid 30616366)
82. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5. (Pubitemid 24216953)
83. Kojima S, Itoh Y, Matsumoto S, Masuho Y, Seiki M. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett 2000;480:142-6.
84. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250. (Pubitemid 23103292)
85. Westermarck J, Kähäri, VM. Regulation of matrix metalloproteinase expression in tumour invasion. FASEB J 1999;13:781-92. (Pubitemid 29220691)
86. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160. (Pubitemid 27230597)
87. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996;393:101-4. (Pubitemid 26298239)
88. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-22. (Pubitemid 27455388)
89. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270:5331-8.
90. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904. (Pubitemid 27017088)
91. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2. (Pubitemid 35425238)
92. Fu P, Jiang X, Arcasoy MO. Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway. Biochem Biophys Res Commun 2009;379:696-701.
93. Webb DJ, Nguyen DH, Gonias SL. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. J Cell Sci 2000;113:123-34. (Pubitemid 30066339)
94. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. ERK is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 2001;276:14443-50.
95. Cuevas BD, Abell AN, Witowsky JA, Yujiri T, Johnson NL, Kesavan K, Ware M, Jones PL, Weed SA, De Biasi RL, Oka Y, Tyler KL, Johnson GL. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J 2003;22:3346-55. (Pubitemid 36834864)
96. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997;137:481-92. (Pubitemid 27181299)
97. Liu ZX, Yu CF, Nickel C, Thomas S, Cantley LG. Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association. J Biol Chem 2002;277:10452-8. (Pubitemid 34968166)
98. Hunger-Glaser I, Salazar EP, Sinnett-Smith J, Rozengurt E. Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation. J Biol Chem 2003;278:22631-43. (Pubitemid 36830321)
99. Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 2004;24:2499-512. (Pubitemid 38326004)
100. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 2004;6:154-61. (Pubitemid 38425715)
101. Allen MP, Linseman DA, Udo H, Xu M, Schaack JB, Varnum B, Kandel ER, Heidenreich KA, Wierman ME. Novel mechanism for gonadotropin-releasing hormone neuronal migration involving Gas6/Ark signaling to p38 mitogen-activated protein kinase. Mol Cell Biol 2002;22:599-613. (Pubitemid 34027504)
102. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. p38 mitogenactivated protein kinase is required for TGF beta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002:115:3193-206.
103. Kotlyarov A, Yannoni Y, Fritz S, Laaß K, Telliez JB, Pitman D, Lin LL, Gaestel M. Distinct cellular functions of MK2. Mol Cell Biol 2002;22:4827-35. (Pubitemid 34620417)
104. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP-kinase cascades. J Biol Chem 2003;278:21989-97. (Pubitemid 36792607)
105. Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal 2000;12:1-13. (Pubitemid 30017963)
106. Hannigan MO, Zhan L, Ai Y, Kotlyarov A, Gaestel M, Huang CK. Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 2 (-/-) neutrophils in Zigmond chambers containing formyl-methionyl-leucyl- phenylalanine gradients. J Immunol 2001;167:3953-61. (Pubitemid 32910841)
107. Martin-Blanco E, Pastor-Pareja JC, Garcia-Bellido A. JNK and decapentaplegic signaling control adhesiveness and cytoskeleton dynamics during thorax closure in Drosophila. Proc Natl Acad Sci USA 2000;97:7888-93. (Pubitemid 30460743)
108. Kaltschmidt JA, Lawrence N, Morel V, Balayo T, Garcia Fernandez B, Pelissier A, Jacinto A, Martinez Arias A. Planar polarity and actin dynamics in the epidermis of Drosophila. Nat Cell Biol 2002;4:937-44. (Pubitemid 35469423)
109. Zhang L, Wang W, Hayashi Y, Jester JV, Birk DE, Gao M, Liu C-Y, Kao W. W-Y, Karin M, Xia Y. A role for MEK kinase 1 in TGF-β/activin-induced epithelium movement and embryonic eyelid closure. EMBO J 2003;22:4443-54. (Pubitemid 37087198)
110. Liang Y, McDonnell S, Clynes M. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2002;2:257-77.
111. Mattern J. Drug resistance in cancer: a multifactorial problem. Anticancer Res 2003;23:1769-72. (Pubitemid 36750846)
112. Schadendordf D, Worm M, Algermissen B, Kohlmus CM, Czarnetzki BM. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer 1994;73:103-8. (Pubitemid 24012729)
113. Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Anticancer Res 1997;17:4359-70. (Pubitemid 28081713)
114. Gottesman MM, Fojo T, Bates SE. Multridrug resistance in cancer: role of AT P-dependent transporters. Nat Rev Cancer 2002;2:48-58. (Pubitemid 37328807)
115. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB, Coon JS. Relationship of the expression of the multidrug resistance gene product (Pglycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991;51:2720-6.
116. Scaddan PB, Dufresne MJ. Characterization of cysteine proteases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells. Invasion Metastasis 1993;13:301-13.
117. Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 1997;150:1571-82. (Pubitemid 27193807)
118. Bradley AL, Chapman WC, Wright JK, Marsh JW, Geevarghese S, Blair KT, Pinson CW. Surgical experience with hepatic colorectal metastasis. Am Surg 1999;65:560-6.
119. Bjørnland K, Lehne G, Johansen HT, Fodstad O, Rugstad HE, Aasen AO, Ree AH. Human hepatoma cells rich in Pglycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells. Oncol Res 1998;10:255-62. (Pubitemid 128736321)
120. Bates RC, Edwards NS, Burns GF, Fisher DE. A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res 2001;61:5275-3.
121. Ohashi R, Takahashi F, Cui R, Yoshioka M, Gu T, Sasaki S, Tominaga S, Nishio K, Tominaga Tabane KK, Takahashi K. Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. Cancer Lett 2007;252:225-34. (Pubitemid 46809789)
122. Yang J-M, Xu Z, Wu H, Zhu H, Wu X, Hait WN. overexpression of extracellular matrix metalloproteinase inducer in multigrug resistant cancer cells. Mol Cancer Res 2003;1:420-7. (Pubitemid 36459252)
123. Zhang F, Shi Y, Zhang L, Zhang B, Wei X, Yang Y, Wang R, Niu R. Epithelial-mesenchymal transition and the expression of Twist in MCF-7/ADR, human multidrug-resistant breast cancer cells. Chinese J Clin Oncol 2007;4:21-5.
124. Ding S, Chamberlain M, McLaren A, Goh L, Duncan I, Wolf CR. Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer 2001;85:1175-4.
125. Yang J-M, Vassil AD, Hait WN. Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) through the Raf-MAPK pathway. Mol Pharmacol 2001;60:674-80. (Pubitemid 32900248)
126. Grotegut S, Von Schweinitz D, Christofori G, Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006;25:3534-45. (Pubitemid 44264864)
127. Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM, Xu ZD. Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glicoprotein substrates in multigrug resistant breast cancer cells. Cancer Sci 2007;98:1767-74. (Pubitemid 47487914)
128. Birch M, Mitchell S, Hart IR. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 1991;51:6660-7.
129. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994;180:53-66. (Pubitemid 24181055)
130. Ponta H, Scherman L, Herrlich PA. CD44: from adesion molecules to signaling regulators. Nat Rev Mol Cell Biol 2003;4:33-45. (Pubitemid 36077255)
131. Brambilla D, Fais S. The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. Int J Cancer 2009;25:2239-45.
132. Federici C, Brambilla D, Lozupone F, Matarrese P, de Milito A, Lugini L, Iessi E, Cecchetti S, Marino M, Perdicchio M, Logozzi M, Spada M, Malorni W, Fais S. Pleiotropic function of ezrin in human metastatic melanomas. Int J Cancer 2009;124:2804-12.
133. Luciani F, Molinari A, Lozupone F, Calcabrini A, Lugini L, Stringaro A, Puddu P, Arancia G, Cianfriglia M, Fais S. P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Blood 2002;99:641-8. (Pubitemid 34533103)
134. Miletti-González KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN, Rodríguez-Rodríguez L. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 2005;65:6660-7. (Pubitemid 41060702)
135. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A, Caraglia M, Budillon A, Meo G, Arancia G and Molinari A. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 2008;128:957-71. (Pubitemid 351374289)
136. Fais S, De Milito A, You H, Qin W. Targeting vacuolar H+-AT Pases as a new strategy against cancer. Cancer Res 2007;67:10627-30. (Pubitemid 350145883)
137. Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, Gentile M, Luciani F, Parmiani G, Rivoltini L, Malorni W, Fais S. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006;66:3629-38.
138. Lozupone F, Perdicchio M, Brambilla D, Borghi M, Meschini S, Barca S, Marino ML, Logozzi M, Federici C, Iessi E, de Milito A, Fais S. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep 2009;10:1348-54.